跳至主要内容
临床试验/NCT03631355
NCT03631355已完成4 期

Reducing Hemarthrosis in Anterior Cruciate Ligament Reconstruction With BTB Autograft by the Administration of Intravenous Tranexamic Acid: A Double-Blind Randomized Control Study

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2018年6月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
110
试验地点
1
主要终点
POST-OPERATIVE HEMARTHROSIS

研究概览

简要总结

The purpose of the proposed study is to evaluate the effects of administering intravenous tranexamic acid (TXA) to patients undergoing anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone autograft to minimize hemarthrosis within the knee joint and post operative pain.

详细描述

The purpose of the proposed study is to evaluate the effects of administering intravenous tranexamic acid (TXA) to patients undergoing anterior cruciate ligament (ACL) reconstruction with bone-patellar tendon-bone autograft to minimize hemarthrosis within the knee joint and post operative pain. Patients received the standard arthroscopic ACL reconstruction with a BTB autograft and were randomized to either receiving or not receiving two individual doses of TXA intra-operatively or receive. The goal of the study is to determine and evaluate the effect of intra-operative TXA on post-operative hemarthrosis, pain reduction, and opioid consumption.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • PATIENTS UNDERGOING AN ACL RECONSTRUCTION WITH BTB AUTOGRAFT

排除标准

  • Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects, dementia, etc.)
  • Younger than 18 years of age
  • Any patient considered a vulnerable subject
  • Have bleeding or clotting disorder
  • Preoperative anticoagulation therapy
  • Abnormal coagulation profile
  • Renal disorder or insufficiency
  • Sickle cell disease

研究组 & 干预措施

ACL Reconstruction w/ BTB Autograft + IV TXA

Active Comparator

Patients receive a standard arthroscopic ACL reconstruction with a BTB autograft. In addition, these selected patients received two individual doses of intravenous TXA intra-operatively.

干预措施: Tranexamic Acid (Drug)

结局指标

主要结局

POST-OPERATIVE HEMARTHROSIS

时间窗: Post-operative week 1

Measured by assessing the operative knee at the first post-operative visit for the need of joint aspiration.

POST-OPERATIVE Patient Reported Pain Score on the Visual Analog Scale (VAS)

时间窗: Post-operative day 7

Pain severity, measured by the Visual Analog Scale (VAS): a scale of 1-10, with 1 being the least amount of pain and 10 being the most amount of pain.

POST-OPERATIVE Opioid Consumption

时间窗: Days 1-7

Each patient's opioid consumption was measured by morphine milligram equivalents (MME).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验